⚙
AI-generated deep summary
by claude@2026-06, 2026-06-07
· read from full text
ⓘ
The paper models endometriosis as a Mode II compensation failure in which compensatory fibrotic wound healing occurs but becomes consolidated toward a pathological attractor. Using a cycle-averaged differential equation that incorporates two nonlinear processes—self-amplifying extracellular matrix stiffening and resolution saturation—the authors derive a closed-form fibrotic locking threshold, ε* = ρ / [ρ + (√α + √(θ/ψ))²], above which the fibrotic attractor is the only stable state for a lesion’s current status, and they prove that both nonlinearities are required for bistability while sufficiency is established separately. They then present four testable predictions, including that anti-platelet modulation of wound initiation rate raises ε*, TGF-β3 restoration of resolution efficiency expands the recoverable basin, and the combination can be non-redundant and super-additive on locking thresholds in a fragile regime; a further structural consequence is that the proposed interventions avoid the hypothalamic–pituitary–ovarian axis and may preserve ovulation relative to hormonal suppression. This paper is centrally about endometriosis — it formally derives the fibrotic locking threshold and predictions for compensation failure mechanisms in endometriosis.
Abstract
Endometriosis affects approximately 190 million women of reproductive age worldwide. Standard management — hormonal suppression, surgical excision, and combined oral contraceptives — controls symptoms but suppresses the reproductive axis, preventing pregnancy as a mechanism of treatment. The gynecological literature has empirically converged on combination approaches pairing injury-rate reduction with antifibrotic therapy, yet no formal account exists of why this combination is non-redundant — recovering lesions neither monotherapy can — rather than merely additive. This paper formalises endometriosis as a candidate instance of Mode II compensation failure: a regime in which a compensatory response (fibrotic wound healing) fires appropriately but its consolidation operator is misaligned toward a pathological attractor. From a cycle-averaged differential equation incorporating two documented nonlinearities — self-amplifying extracellular matrix (ECM) stiffening and resolution saturation — we derive a closed-form locking threshold ε* = ρ / [ρ + (√α + √(θ/ψ))²]: the misalignment above which, for a lesion at its current state, the fibrotic attractor is the only stable state. We prove that neither nonlinearity alone produces bistability; both are required (necessity), and sufficiency is established separately. Three testable predictions follow. (i) Anti-platelet modulation of wound-initiation rate raises ε*, slowing progression in early-stage disease. (ii) TGF-β3 restoration of resolution efficiency expands the recoverable basin. (iii) The combination is non-redundant and, in the fragile regime (ε* < 1/2), super-additive on the locking threshold — recovering lesions neither monotherapy reaches. As a structural consequence, because none of the intervention targets involves the hypothalamic–pituitary–ovarian axis, the combination preserves ovulation where hormonal suppression does not. A worked example illustrates how the ε* structure suggests separating dienogest's fibrotic benefit from its fertility cost via direct myofibroblast apoptosis induction combined with anti-platelet therapy. All predictions are falsifiable with existing or obtainable data. This paper is part of a program on formal frameworks for biological compensation. The companion framework paper is posted at DOI: 10.5281/zenodo.20515948.
Full text
2,852 characters
· extracted from
oa-doi-fallback
· click to expand
Mode II Compensation Failure in Endometriosis: A Formal Derivation of the Fibrotic Locking Threshold and Four Testable Predictions
Description
Endometriosis affects approximately 190 million women of reproductive age worldwide. Standard management — hormonal suppression, surgical excision, and combined oral contraceptives — controls symptoms but suppresses the reproductive axis, preventing pregnancy as a mechanism of treatment. The gynecological literature has empirically converged on combination approaches pairing injury-rate reduction with antifibrotic therapy, yet no formal account exists of why this combination is non-redundant — recovering lesions neither monotherapy can — rather than merely additive.
This paper formalises endometriosis as a candidate instance of Mode II compensation failure: a regime in which a compensatory response (fibrotic wound healing) fires appropriately but its consolidation operator is misaligned toward a pathological attractor. From a cycle-averaged differential equation incorporating two documented nonlinearities — self-amplifying extracellular matrix (ECM) stiffening and resolution saturation — we derive a closed-form locking threshold ε* = ρ / [ρ + (√α + √(θ/ψ))²]: the misalignment above which, for a lesion at its current state, the fibrotic attractor is the only stable state. We prove that neither nonlinearity alone produces bistability; both are required (necessity), and sufficiency is established separately.
Three testable predictions follow. (i) Anti-platelet modulation of wound-initiation rate raises ε*, slowing progression in early-stage disease. (ii) TGF-β3 restoration of resolution efficiency expands the recoverable basin. (iii) The combination is non-redundant and, in the fragile regime (ε* < 1/2), super-additive on the locking threshold — recovering lesions neither monotherapy reaches. As a structural consequence, because none of the intervention targets involves the hypothalamic–pituitary–ovarian axis, the combination preserves ovulation where hormonal suppression does not. A worked example illustrates how the ε* structure suggests separating dienogest's fibrotic benefit from its fertility cost via direct myofibroblast apoptosis induction combined with anti-platelet therapy. All predictions are falsifiable with existing or obtainable data.
This paper is part of a program on formal frameworks for biological compensation. The companion framework paper is posted at DOI: 10.5281/zenodo.20515948.
Files
Pan_ModeII_Endometriosis_v1.pdf
Files
(355.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4ff87685ff21e73ef1a94614d31e08d1
|
355.1 kB | Preview Download |
Additional details
Related works
- Is part of
- Preprint: 10.5281/zenodo.20515948 (DOI)
- Preprint: 10.5281/zenodo.20441516 (DOI)
- Preprint: 10.5281/zenodo.20102071 (DOI)
Dates
- Created
-
2026-06-03
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.